Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease
about
Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany StudyFibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure.Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.Correlates and Longitudinal Renal and Cardiovascular Implications of FGF23 Levels in HIV-Positive Individuals.Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy.Beyond cardiac troponin: recent advances in the development of alternative biomarkers for cardiovascular disease.Elevation of plasma oncostatin M in heart failure.Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload.Fibroblast Growth Factor-23 Fans the Flames of Heart and Kidney FailureAssociation of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.Phosphate and Cardiovascular Disease beyond Chronic Kidney Disease and Vascular Calcification.Paracrine Effects of FGF23 on the Heart.Research update for articles published in EJCI in 2012Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II
P2860
Q28084197-AF7B6B27-EB1B-4A03-90CF-6E5635B66F4DQ30316351-163557BC-942A-40DC-87AF-F4DD5E13F255Q35008805-FCE8CFFC-55D9-4F6C-B7E1-FD88226236AAQ35755817-E5F9424E-4C10-4E51-A28F-1F410366E6E2Q35997370-A1253CAF-B5D8-46BC-AC50-CA14E0B8F3EAQ36016861-2B3DF50D-FD8E-4EF0-96B7-1477C22D74BDQ37432867-F2C0A3A6-CFA9-4A08-8466-A7E796044C3DQ38353580-D75399F3-72D5-45AF-8A4F-B1DC7ED03950Q38674256-D55A5AD0-2A75-4DC6-9C98-8795E07F60E4Q41200048-707A3B2E-FDCD-42FD-A4E8-96DD41FD3F4DQ42333448-3C4F6692-AF6E-4E21-A1A9-C116283182B7Q52667905-9BF00F9E-615D-44D9-B7F1-274CF81A2572Q55098165-3A65071A-3DC3-4B9B-A21B-FFB4BC083278Q55221465-9B74B97A-AE2C-4D96-B576-4570EEC88B60Q57913380-E2503642-9557-4CE4-8807-909C19966396Q58770788-259BC2EC-3B77-4606-908D-B9CBEF3DFE6B
P2860
Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Fibroblast growth factor-23, c ...... stable ischemic heart disease
@ast
Fibroblast growth factor-23, c ...... stable ischemic heart disease
@en
Fibroblast growth factor-23, c ...... stable ischemic heart disease
@nl
type
label
Fibroblast growth factor-23, c ...... stable ischemic heart disease
@ast
Fibroblast growth factor-23, c ...... stable ischemic heart disease
@en
Fibroblast growth factor-23, c ...... stable ischemic heart disease
@nl
prefLabel
Fibroblast growth factor-23, c ...... stable ischemic heart disease
@ast
Fibroblast growth factor-23, c ...... stable ischemic heart disease
@en
Fibroblast growth factor-23, c ...... stable ischemic heart disease
@nl
P2093
P2860
P50
P1476
Fibroblast growth factor-23, c ...... stable ischemic heart disease
@en
P2093
Amit N Vora
David A Morrow
Elaine B Hoffman
Marc A Pfeffer
Marc S Sabatine
Petr Jarolim
Sarah Sloan
Scott D Solomon
Thomas F O'Donnell
P2860
P304
P356
10.1016/J.JACC.2014.03.026
P407
P577
2014-04-09T00:00:00Z